CXCL4 drives fibrosis by promoting several key cellular and molecular processes

Area of Science:

• Immunology
• Pathology
• Cell Biology

Background:

• Fibrosis is a significant global health concern, marked by myofibroblast activation and excessive extracellular matrix deposition.
• Systemic sclerosis is a key fibrotic disease where elevated CXCL4 correlates with disease severity.

Purpose of the Study:

• To investigate the role of chemokine CXCL4 in the development of fibrosis.
• To explore CXCL4 as a potential therapeutic target for fibrotic conditions.

Main Methods:

• Utilized CXCL4-deficient mice and human CXCL4 overexpression models.
• Analyzed fibrotic events in skin, lungs, and heart.
• Performed single-cell ligand-receptor analysis and in vitro cell differentiation assays.

Main Results:

• CXCL4 levels were elevated in multiple fibrotic mouse models.
• CXCL4 deficiency protected against fibrosis, while overexpression exacerbated it.
• CXCL4 directly induced myofibroblast differentiation and collagen synthesis via endothelial-to-mesenchymal transition.

Conclusions:

• CXCL4 plays a critical role in promoting fibrotic processes.
• Targeting CXCL4 presents a promising therapeutic avenue for treating fibrosis.